Search for Clinical Trial Results

Sponsored By

Meningeal Neoplasms - 25 Studies Found

Status Study
Completed Study Name: Intrathecal Mafosfamide
Condition: Malignant Meningeal Neoplasms
Date: 2003-06-17
Interventions: Drug: Intrathecal Mafosfamide
Completed Study Name: DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor
Condition: Meningeal Neoplasms
Date: 2002-01-15
Interventions:
  • Drug: Intrathecal (injected into the spinal fluid) DepoCyt
Completed Study Name: Phase I Study of Intrathecal Mafosfamide
Condition:
  • Leukemia
  • Lymphoma
  • Meningeal Neoplasm
    Date: 2006-07-07
    Interventions: Drug: Mafosfamide
Completed Study Name: Phase I Study of Intrathecal Topotecan
Condition:
  • Leukemia
  • Lymphoma
  • Meningeal Neoplasm
    Date: 1999-11-03
    Interventions: Drug: topotecan
Terminated Study Name: S9624 Ifosfamide in Treating Patients With Meningeal Tumors
Condition:
  • Chondrosarcoma
  • Adult Fibrosarcoma
  • Adult Leiomyosarcoma Date: 1999-11-01
    Interventions: Drug: ifosfamide
Completed Study Name: Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors
Condition: Brain and Central Nervous System Tumors
Date: 2002-03-08
Interventions: Drug: mafosfamide
Terminated Study Name: Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System
Condition:
  • Leukemia
  • Lymphoid Malignancies
  • Metastatic Malignant Neopla
    Date: 2012-05-08
    Interventions: Drug: Intrathecal Rituximab Phase I: Starting dose Rituxim
Terminated Study Name: Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma
Condition:
  • Brain Tumors
  • Central Nervous System Tumors
  • Leptomeningeal
    Date: 2000-06-02
    Interventions: Drug: temozolomide
Recruiting Study Name: Pembrolizumab in Patients With Leptomeningeal Disease
Condition: Patients With Leptomeningeal Disease
Date: 2017-01-03
Interventions: Drug: Pembrolizumab 200mg every 3 weeks
Withdrawn Study Name: Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease
Condition: Leptomeningeal Metastases
Date: 2011-09-19
Interventions:
  • Other: pharmacological study C
Next >>>